Carcinogenesis in IBD: potential targets for the prevention of colorectal cancer.
about
Mucins in cancer: function, prognosis and therapyStatus of colitis-associated cancer in ulcerative colitisDeath-associated protein kinase: A molecule with functional antagonistic duality and a potential role in inflammatory bowel disease (Review)KRAS and TP53 mutations in inflammatory bowel disease-associated colorectal cancer: a meta-analysis.Matrix metalloproteinase-9 functions as a tumor suppressor in colitis-associated cancerGFI1 downregulation promotes inflammation-linked metastasis of colorectal cancer.Interferon-gamma regulates intestinal epithelial homeostasis through converging beta-catenin signaling pathways.Epimorphin deletion protects mice from inflammation-induced colon carcinogenesis and alters stem cell niche myofibroblast secretion.Relationship between methylation and colonic inflammation in inflammatory bowel disease.2,3',4,4',5'-Pentamethoxy-trans-stilbene, a resveratrol derivative, inhibits colitis-associated colorectal carcinogenesis in miceCurrent management of inflammatory bowel disease and colorectal cancer.Microbial imbalance and intestinal pathologies: connections and contributionsRecent advancement in understanding colitis-associated tumorigenesis.Interleukin-6 mediated upregulation of CYP1B1 and CYP2E1 in colorectal cancer involves DNA methylation, miR27b and STAT3.Interplay between DNA repair and inflammation, and the link to cancerLyn activity protects mice from DSS colitis and regulates the production of IL-22 from innate lymphoid cells.Association between appendectomy and subsequent colorectal cancer development: an Asian population study.MTGR1 is required for tumorigenesis in the murine AOM/DSS colitis-associated carcinoma modelNotch1 regulates the effects of matrix metalloproteinase-9 on colitis-associated cancer in mice.Combination of atorvastatin with sulindac or naproxen profoundly inhibits colonic adenocarcinomas by suppressing the p65/β-catenin/cyclin D1 signaling pathway in rats.Differential microRNA expression tracks neoplastic progression in inflammatory bowel disease-associated colorectal cancer.Implications of microRNAs in colorectal cancer development, diagnosis, prognosis, and therapeutics.The Role of Curcumin in Modulating Colonic Microbiota During Colitis and Colon Cancer PreventionThe role and pathophysiological relevance of membrane transporter PepT1 in intestinal inflammation and inflammatory bowel disease.Comparative analysis of copy number variations in ulcerative colitis associated and sporadic colorectal neoplasia.Intestinal inflammatory cytokine response in relation to tumorigenesis in the Apc(Min/+) mouse.Infection-induced colitis in mice causes dynamic and tissue-specific changes in stress response and DNA damage leading to colon cancer.Identification of a genetic locus controlling bacteria-driven colitis and associated cancer through effects on innate inflammationAID-expressing epithelium is protected from oncogenic transformation by an NKG2D surveillance pathway.Therapeutic effects of mouse bone marrow-derived clonal mesenchymal stem cells in a mouse model of inflammatory bowel disease.Mulberry fruit prevents LPS-induced NF-κB/pERK/MAPK signals in macrophages and suppresses acute colitis and colorectal tumorigenesis in mice.IFN-γ and TNF-α-induced GBP-1 inhibits epithelial cell proliferation through suppression of β-catenin/TCF signalingProhibitin attenuates colitis-associated tumorigenesis in mice by modulating p53 and STAT3 apoptotic responses.NOD2-mediated dysbiosis predisposes mice to transmissible colitis and colorectal cancer.The diverse roles of nonsteroidal anti-inflammatory drug activated gene (NAG-1/GDF15) in cancer.Inflammation and colorectal cancer: colitis-associated neoplasia.Sonic hedgehog inhibitors prevent colitis-associated cancer via orchestrated mechanisms of IL-6/gp130 inhibition, 15-PGDH induction, Bcl-2 abrogation, and tumorsphere inhibition.Chemical and cytokine features of innate immunity characterize serum and tissue profiles in inflammatory bowel diseaseEpigenetics and colorectal cancer pathogenesisCritical role of PepT1 in promoting colitis-associated cancer and therapeutic benefits of the anti-inflammatory PepT1-mediated tripeptide KPV in a murine model.
P2860
Q24633765-F6597ACA-C6AF-4987-8410-C1EF23E9DC69Q26751745-00E1B80B-13CC-48BA-8AA2-FC77493A957EQ28083490-FA805DFA-43AB-407A-B087-3DA35CE4C895Q33591865-12C6D172-90F4-4D5D-A305-61618EA37B63Q33652022-C26F0545-0696-43C8-8CC9-0EB5D55754E8Q33652169-B90B0C35-A398-4449-A33A-EDA5A744CFA0Q33808592-617F27D7-B959-42A1-9C44-C55C41A92BF4Q33882885-192553A1-4C23-4AB2-A032-18FBAF6E88E2Q34036817-780285D2-2F90-4AE0-80A9-9C114BE373ACQ34124800-4626FF97-BE3F-4F1E-B1EC-1E37BABF2CC6Q34192660-1C6B66F4-1661-4DA5-AB59-1DF5D156E1F3Q34241115-BEA93ED6-BEB2-45E5-94DA-77C8DBA7CE95Q34390271-682AABF5-D785-42AA-AC09-3A5B621B114AQ34687041-C0C17755-05B6-49B4-8D12-8E5E3C788A20Q34989590-AA84F730-6EE8-4EDB-B1FA-1B0A9597CB95Q34991544-ECEBFDF2-4BE5-4611-9B66-CC7C988354B1Q35117711-2F3425F1-9926-47B6-B22B-98C8933E6980Q35147203-4242A580-591D-4509-B754-7900F477DF56Q35269377-310F8C1F-4D3F-474A-8E5B-FF8B8A93E432Q35522954-04176ED4-2CC0-4CFB-8D75-713A1C001AEBQ35541869-3C314609-B948-4BAD-87DE-1884B9153851Q35565247-76F7A40C-8770-4A49-911B-7A39914A1E83Q35719398-FE18849A-7DF8-4674-A16D-2F6B196232D4Q35849969-B2F8A95D-1EB9-407E-B646-1C18F5AE7105Q35990690-69BC1DEF-CF71-410A-B807-882C9AF476F9Q36008516-0E3C1838-111B-4F26-A0E9-5C9456BD9154Q36079440-F991FC2D-2757-48D1-880C-28DE6754C19EQ36118315-9FD1A6EA-696D-4713-BC95-2E51987907F7Q36159467-A61E5A6D-AB0E-423F-B4FF-D651C630C6F7Q36265369-DD0C9746-3DE5-4B01-A7F4-92C200E884E7Q36329988-EDD23FB6-3CE7-4B9C-8507-B56708415DD3Q36346795-18E92707-244D-4CBD-83CB-C3635432D4E5Q36405897-130C533D-AFB0-41FA-BBB8-FCF73868A39DQ36580437-E4C5678A-11C0-4553-BA90-0CD2A20B94F1Q36592451-F11F7576-746C-440E-A09D-7C778B27BC38Q36597803-A50318CA-8D47-45F6-831A-2D7B94362C3EQ36946582-C104BDB1-6725-4504-97BF-1B75DC6F8967Q36967764-DEB5C65E-576E-45BB-A33C-7C2B722B2A78Q37061792-78390C81-9372-4759-8DEA-4E6D3943AB49Q37119616-631EB51C-B3CB-4B58-BFFA-A57AD2FEA696
P2860
Carcinogenesis in IBD: potential targets for the prevention of colorectal cancer.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on May 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Carcinogenesis in IBD: potential targets for the prevention of colorectal cancer.
@en
Carcinogenesis in IBD: potential targets for the prevention of colorectal cancer.
@nl
type
label
Carcinogenesis in IBD: potential targets for the prevention of colorectal cancer.
@en
Carcinogenesis in IBD: potential targets for the prevention of colorectal cancer.
@nl
prefLabel
Carcinogenesis in IBD: potential targets for the prevention of colorectal cancer.
@en
Carcinogenesis in IBD: potential targets for the prevention of colorectal cancer.
@nl
P2093
P2860
P356
P1476
Carcinogenesis in IBD: potential targets for the prevention of colorectal cancer.
@en
P2093
Linda A Feagins
Rhonda F Souza
Stuart J Spechler
P2860
P2888
P304
P356
10.1038/NRGASTRO.2009.44
P407
P577
2009-05-01T00:00:00Z
P6179
1051881178